Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
350
-
Total 13F shares, excl. options
-
67.6M
-
Shares change
-
+216K
-
Total reported value, excl. options
-
$5.24B
-
Value change
-
+$20.3M
-
Put/Call ratio
-
0.09
-
Number of buys
-
162
-
Number of sells
-
-144
-
Price
-
$77.53
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2021
400 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2021.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 350 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.6M shares
of 115M outstanding shares and own 58.65% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.35M shares), VANGUARD GROUP INC (7.25M shares), JANUS HENDERSON GROUP PLC (6.16M shares), WELLINGTON MANAGEMENT GROUP LLP (3.91M shares), STATE STREET CORP (2.12M shares), Capital Research Global Investors (2.05M shares), RTW INVESTMENTS, LP (1.67M shares), Champlain Investment Partners, LLC (1.52M shares), GW&K Investment Management, LLC (1.5M shares), and AXA S.A. (1.47M shares).
This table shows the top 350 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.